Agard Investments, Inc.

Grünenthal is a global leader in pain management, driven by a passion for innovation and a vision of a world free of pain. They are dedicated to developing effective medicines and solutions for patients with severe diseases and high unmet medical needs. With a strong focus on corporate responsibility, Grünenthal strives to create a net positive impact for patients, employees, partners, and society as a whole. They prioritize compliance, ethics, and transparency, while also promoting responsible use of pain medication and increasing accessibility to treatments.Generated from the website